Clinerion Expands in Poland
EMC Szpitale augments Clinerion’s patient coverage in Poland by joining the Patient Network Explorer platform. Patients at the hospital group will gain access to clinical trials, and actively support the launch of medical treatments.
Joining Clinerion’s hospital partner network gives EMC Spitale visibility to trial sponsors on their readiness to participate in clinical research on an international level. EMC Szpitale patients will gain access to clinical care as the Patient Network Explorer draws international clinical studies to the hospital group, directly to the patients.
EMC Szpitale operates 11 hospitals and 19 outpatient clinics, providing primary and specialized medical care to over one million patients across Poland. EMC Szpitale specializations include advanced diagnostics to comprehensive hospital treatment in gastroenterology, rehabilitation, urology, orthopedics, general surgery, gynecology, obstetrics and geriatric care. Currently, the hospital group is running 37 different clinical trials.
EMC Szpitale uses an artificial intelligence technology supporting oncologists in choosing optimal cancer treatments. With their focus on geriatric care, EMC Szpitale is a partner of the nationwide social campaign ‘Understand Old Age’. The hospital group pioneers innovative ways of thinking and operational processes. The implementation of Lean Management at the hospital in Lubin has been recognized with the award for the Innovative Hospital 2017 in the Success of the Year in Healthcare competition.
“We care for our patients. Everyday. In a better way. That’s why we work to increase interest and enrollment in clinical trials to ultimately ensure greater availability of innovative therapies for our patients,” says Anna Szewczuk-Lebska, spokesperson for EMC Szpitale.
“Sponsors are looking for trials sites with the highest levels of care, therapeutic experience and clinical experts,” says Ian Rentsch, Clinerion CEO. “EMC Spitale’s broad therapeutic coverage and geographical situation make it a great partner for them and for Clinerion.”
To learn more go to www.clinerion.com
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
